Moderna, Inc.

Headquarters: Cambridge, MA, United States

Founded: September 2010

Employees: 2,700

CEO: Mr. Stephane Bancel

show_chart NASDAQ: MRNA +1.30%

Market Cap

$68.42 Billion

USD as of Jan. 1, 2023

history Market Cap History

Company Description

Moderna, Inc. is a biotechnology company, specialized in vaccine technology based on messenger RNA. It is notably famous for producing one of the first vaccines against Covid-19, and it is also developing and patenting other vaccine candidates for seasonal flu, HIV, the Nipah virus, and a second COVID-19 vaccine.

Moderna, Inc. market capitalization over time

Evolution of Moderna, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Moderna, Inc.

Detailed Description

Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States and internationally. The company has 44 development programs, which includes 26 in clinical trials across seven modalities comprising prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic intracellular therapeutics, and inhaled pulmonary therapeutics. The company has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Stocks & Indices

Moderna, Inc. has the following listings and related stock indices.


Stock: BMV: MRNA

Stock: Bovespa: M1RN34

Stock: FSX: 0QF

Product & Services

Moderna COVID-19 vaccine

Key People

Founder(s): Derrick Rossi Timothy A. Springer Robert S. Langer Kenneth R. Chien Noubar Afeyan

Stéphane Bancel, CEO Stephen Hoge, President David Meline, CFO Noubar Afeyan, Chairman Robert S. Langer, Director Paul Sagan, Director


Revenue: US$18.5 billion (2021)

Operating income: US$13.3 billion (2021)

Net income: US$12.2 billion (2021)

Total assets: US$24.7 billion (2021)

Total equity: US$24.7 billion (2021)



200 Technology Square

Cambridge, MA 02139

United States

Phone: 617 714 6500

Fax: 617 583 1998